Anzeige
Mehr »
Login
Freitag, 19.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Goldaktie: Eine Erfolgsgeschichte, die seinesgleichen sucht, startet gerade richtig durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Business Wire-Archiv vom 01.12.2018

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
01.12.18Golden Euro Casino Gets into the Christmas Spirit with Special Advent Calendar289Players open doors to reveal a total of 1,000 daily free spins worth €450 that can be played across a huge range of festive slots Christmas has come early for players at exciting...
► Artikel lesen
01.12.18bluebird bio Presents Updated Data from Clinical Studies of LentiGlobin Gene Therapy in Transfusion-Dependent ß-Thalassemia and Sickle Cell Disease at 60th Annual Meeting of the American Society of Hematology506All patients with transfusion-dependent ß-thalassemia and a non-ß00 genotype who achieved transfusion independence continue to maintain it for up to 3.5 years in Phase 1/2 Northstar (HGB-204)...
► Artikel lesen
01.12.18Darzalex - (daratumumab) Combination Regimens Show Positive Results for Newly Diagnosed and Relapsed Patients with Multiple Myeloma363Updated Phase 3 ALCYONE results featured as oral presentation at ASH 2018 show improved progression-free survival in newly diagnosed patients Data from Phase 2 LYRA and GRIFFIN studies...
► Artikel lesen
01.12.18Oxford BioMedica Notes the Longer-Term Analyses from Pivotal Kymriah Trials, Which Showed Durable Responses Are Maintained in Patients with Advanced Blood Cancers409Oxford BioMedica plc ("Oxford BioMedica" or "the Group") (LSE:OXB), a leading gene and cell therapy group, today notes an announcement by Novartis on the longer-term analyses of both the...
► Artikel lesen
01.12.18At ASH, Extended Half-Life Therapies ELOCTATE and ALPROLIX Demonstrate Proven Efficacy and Well-Characterized Safety over Four Years164ASPIRE and B-YOND extension studies show no inhibitor development and consistently low annualized bleeding rates in study participants over four years with ELOCTATE and ALPROLIX, respectively...
► Artikel lesen
01.12.18Tokyo Gas wechselt zu Rimini Street für Support seiner SAP-Anwendungen309Der führende japanische Energieversorger maximiert ROI über zentrales SAP-System und erhält gleichzeitig erstklassigen Support Rimini Street, Inc. (Nasdaq: RMNI), ein globaler Anbieter...
► Artikel lesen
01.12.18P&G Completes Acquisition of the Consumer Health Business of Merck KGaA, Darmstadt, Germany415Today, the Procter Gamble Company (NYSE: PG) announced the successful completion of its acquisition of the Consumer Health business of Merck KGaA, Darmstadt, Germany. This move improves P&G's...
► Artikel lesen